{"cik":1778922,"taxonomy":"us-gaap","tag":"NetIncomeLoss","label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","entityName":"SpyGlass Pharma, Inc.","units":{"USD":[{"start":"2024-01-01","end":"2024-12-31","val":-29164000,"accn":"0001778922-26-000020","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-26","frame":"CY2024"},{"start":"2025-01-01","end":"2025-03-31","val":-8823000,"accn":"0001778922-26-000035","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-14"},{"start":"2025-01-01","end":"2025-03-31","val":-8823000,"accn":"0001778922-26-000045","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-06","frame":"CY2025Q1"},{"start":"2025-01-01","end":"2025-06-30","val":-17498000,"accn":"0001778922-26-000045","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-06"},{"start":"2025-04-01","end":"2025-06-30","val":-8675000,"accn":"0001778922-26-000045","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-06","frame":"CY2025Q2"},{"start":"2025-01-01","end":"2025-12-31","val":-39869000,"accn":"0001778922-26-000020","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-26","frame":"CY2025"},{"start":"2026-01-01","end":"2026-03-31","val":-13818000,"accn":"0001778922-26-000035","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-14"},{"start":"2026-01-01","end":"2026-03-31","val":-13818000,"accn":"0001778922-26-000045","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-06","frame":"CY2026Q1"},{"start":"2026-01-01","end":"2026-06-30","val":-33682000,"accn":"0001778922-26-000045","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-06"},{"start":"2026-04-01","end":"2026-06-30","val":-19864000,"accn":"0001778922-26-000045","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-06","frame":"CY2026Q2"}]}}